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Background: The objective of this study was to explore effects of khat (Catha edulis) on outcome of rodent malaria
infection and its anti-plasmodial activities on Plasmodium berghei ANKA (PbA).
Methods: Female Swiss albino mice were orally treated with crude khat (Catha edulis) extracts (100, 200 and 300 mg/kg)
on a daily basis for 4 weeks prior to PbA infection. Physical, clinical, hematological, biochemical and histo-pathological
features of the mice were assessed. In addition, in vivo anti-plasmodial activities of khat were evaluated.
Results: The finding of this study showed that khat use was strongly associated with increment of levels of liver and
kidney biomarkers, leucopenia, severe anemia, rise in level of inflammation biomarkers: C-reactive protein (CRP), uric
acid (UA), increased monocyte-lymphocyte count ratio (MLCR), manifestation of cerebral malaria symptoms such as
ataxia, paralysis and deviation of the head but with no pulmonary edema. Significantly lower level of parasitemia
(P < 0.05), rectal temperature, but, high level of hemoglobin were observed at the early stage of the PbA infection in
khat treated mice than the control. With extension of the treatment period, however, drastic increments were observed
in parasite load and rectal temperature although there was reduction in hemoglobin (Hb) level. Moreover, khat showed
poor anti-plasmodial activity with <10% parasite suppression activity and lack protection against major malaria
symptoms. The significant reduction (P < 0.01) of hematological parameters during PbA infection strengthen the notion
that hematological parameters could be good predictors of severe malaria complications in human.
Conclusions: In mice model treated with khat prior to infection with the rodent malaria parasite, khat was found to
worsen manifestation of most malaria complications. Furthermore, the same plant showed poor in vivo anti-plasmodial
activity and protection against major malaria symptoms.
Keywords: Cerebral malaria, Leucopenia, Pulmonary edema, P. berghei, ThrombocytopeniaBackground
Khat (Catha edulis, Forsk), a natural stimulant, is chewed
by millions of people in Yemen, Somalia, Ethiopia,
Djibouti and Kenya [1]. Nowadays, the habit of khat chew-
ing is spreading to Europe, North America, Australia and
Canada [2-4]. Besides its stimulating role, the processed
leaves and roots of the plant are used for treatment of
various ailments including influenza, cough, asthma, gon-
orrhea, vomiting and headache [1,5]. In addition, some* Correspondence: tsigeketema@gmail.com
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unless otherwise stated.endogenous people of East Africa and Meru tribe of Kenya
use khat to treat malaria [1,5-7]. Similarly, some people in
Yemen use khat for treatment of obesity, suppression of
appetite and to alleviate their headaches by inhaling the
fumes of burning khat leaves [8].
Khat contains compounds such as alkaloids, terpe-
noids, flavonoids, sterols, glycosides, tannins, amino
acids, vitamins and minerals [9]. However, the stimulat-
ing effect of khat is mainly associated with its alkaloids
content, cathinone and to a lesser extent cathine and nor-
ephedrine [10]. Cathinone is an intermediate metabolite in
the biosynthesis of cathine which is found mainly in young
fresh leaves of khat plant [10]. Khat, when chewed, is rap-
idly absorbed after oral administration, and it reaches peakl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of khat [11,12]. Cathinone is relatively unstable and de-
composes within few days of picking, or if the leaf is dried,
it changes into cathine and norephedrine [13].
Several reports showed that khat could cause different
health problems including increased susceptibility to cog-
nitive impairment, cardiovascular disorders, stomach ulcer
and increment in adrenocorticotrophic hormone levels. It
also causes urine retention and gall bladder motility,
gastro-intestinal tract constipation and hemorrhage due to
tannin and norpesudoephedrine content of the plant
[1,14-16]. Despite its publicized health consequences, the
practice of khat use is increasing globally and becoming
an everyday drug for most people of East Africa, including
Ethiopia [16].
The co-existence of khat chewing habit and malaria
endemicity in some parts of Ethiopia and people’s per-
ception on medicinal value of the plant against malaria
infection initiate an assumption that khat might have an
effect on the outcome of malaria infection. This
prompted the current study aimed to explore in vivo ef-
fect of crude khat extract on the outcome of malaria in-
fection and its anti-plasmodial activity under controlled




In this study female Swiss albino mice, aged 7–8 weeks,
weighing 25-30 g, obtained from Ethiopian Public
Health Institute (EPHI), Addis Ababa, were used. The
mice were housed in transparent plastic cage having SS
sipper 250 ml water bottle. Wood shaving was used as
bedding and it was replaced every morning after the
cage was cleaned and disinfected with 70% alcohol. The
animals were kept under unlimited access to commercial
pellet food and fresh tap water ad libitum. The experi-
mental room had 12/12 hrs light/dark cycles, 55% ± 5.7
relative humidity and 21°C mean temperature.
Collection and extraction of khat
Fresh khat leaves were purchased from a local market.
Shoot and leaves were carefully picked and chopped into
small pieces (~0.5 cm2) using grinding machine and
mixed in methanol (analytical grade). For 100 g of the
plant, 300 ml of methanol was used. Methanol was
chosen as extraction solvent since it was known to pro-
duce an extract with appreciable levels of cathinone,
cathine and norephedrine from khat [17]. First phase ex-
traction was carried out by spinning the mixture for
15 minutes in Water Bath Shaker (RSB-12) at 120 rpm
and room temperature under dark condition. The mix-
ture was filtered using Whatmann filter paper (11 μm
pore size), and the residue was re-shaked overnightunder the same condition of the former filtrate. Then, the
filtrate was concentrated to near dryness using Rota vapor
(Heidolph Labo Rota, 4002) at 120 rpm and temperature
of 40°C for 1-2 hrs. The residue was measured and dis-
solved in 20% Tween 80 in physiological saline solution.
Freshness of the khat extract was checked on thin
layer chromatography (TLC) following the procedure
developed by Lee [18]. Briefly, the plant extract was
spotted directly onto a pre-coated silica gel 60 plate.
Cathinone oxalate and cathine oxalate drug standards
dissolved in methanol were used as references. The plate
was developed in solvent composition of ethyl acetate,
methanol and aqueous ammonia with respective propor-
tion of 85:10:5, and viewed under an ultraviolet lamp
(254 nm). The spots were visualized using 0.5% ninhyd-
rin solution, and the plate was heated. Cathine appeared
purple, while cathinone was a burnt orange moving spot.
The Rf (retardation factor) values obtained for cathinone
and cathine were 0.43 and 0.21, respectively.
Acute toxicity testing
Sixteen female Swiss albino mice were randomly divided
into 2 groups of 8 mice each. After 2 hrs fasting [19,20],
the first and second groups were treated with 500 and
1000 mg/kg of khat extracts, respectively. The animals
were checked for two weeks daily for any sign of toxicity
such as loss of appetite, hair erection, lacrimation, tremors,
convulsions, salivation, diarrhoea, mortality and other signs
of overt toxicity [19].
Mice grouping and treatment
After a one week period of acclimatization in the labora-
tory, the mice (n = 64) were grouped into eight categor-
ies (I-VIII), each containing 8 mice. The first two groups
(I-II) were treated with 100 mg/kg of khat extract; the
second two groups (III and IV) were treated with
200 mg/kg, while the third two groups (V and VI) were
treated with 300 mg/kg of khat extracts daily for 4 weeks
following the extract doses used by Girma and Engdawork
[21]. The remaining two groups (VII and VIII) were ex-
posed to 0.5 ml of 20% Tween 80 in physiological saline
solution for the same duration, frequency and route of ad-
ministration where one (VII) was used as positive control
after infected with Plasmodium berghei ANKA (PbA) and
the other (VIII) as negative control as indicated in the
following section.
Parasite preparation and mice infection
PbA parasite was obtained from infected mice, carrying
30% of parasitemia, donated by EPHI. After the mice
were terminally anesthetized using diethyl ether and ex-
posure in a closed container, the infected blood was col-
lected through cardiac puncture, and diluted to 1 × 105
PRBCs in PBS. One subgroup from the duplicates of
Ketema et al. BMC Infectious Diseases  (2015) 15:170 Page 3 of 11first, second and third groups (I, III, and V) were treated
with 100, 200 and 300 mg/kg of khat extract, respect-
ively. The positive control (VII) was infected with
100 μL of the diluted PRBCs (1 × 105) in PBS through
intra- peritoneal (i.p.) injection on the last day of the 4th
week of the treatment period. Briefly, the experimental
animals were divided into groups: (1) neither treated nor
infected (n = 8 mice), (2) only treated with khat extract
(100, 200 and 300 mg/kg) (n = 24 mice) daily for four
weeks but not infected with PbA, (3) PbA infected, but
non khat-treated mice used as positive control (n = 8
mice) and (4) PbA infected and khat treated mice (100,
200 and 300 mg/kg) (n = 24 mice) daily for four weeks.
Then, the treatment of all mice exposed to methanolic
khat extract was extended to day 7 of post infection
(7dpi). Starting from 2dpi to the last day of survival of
mice (day 7), parasite load, rectal temperature, body
weight and Hb levels were monitored.
On the seventh day of post infection, rectal temperature
was measured, body weight was taken and few drops of
blood samples from tail snip were used for measurement
of hemoglobin (Hb) level (Hb analyzer, Hemocue™ haemo-
globinometer, Angelholm, Sweden). Parasite load was de-
termined in blood smears, thin and thick, from tail snip
stained in 10% Giemsa for 10 min. Percent (%) parasite
load was calculated by dividing infected RBCs to total
RBCs and multiplying by 100. Parasite loads of nicotine
treated mice were compared with the positive control.
Assessment of severe malaria syndromes
Incidences of clinical signs of cerebral malaria (CM) that
involve neurological syndromes were assessed. These
were ataxia, paralysis, deviation of the head, convulsions,
decrease in body temperature, loss of vascular cell integ-
rity, tissue edema, hemorrhages in the brain of mice,
and congestion of micro-vessels with parasitized erythro-
cytes and/or mononuclear cells [22].
After clinical and physical conditions assessment, each
mouse was terminally anesthetized, and blood sample was
collected through cardiac puncture for hematological and
biochemical tests. Furthermore, some organs such as kid-
ney, liver, spleen, and brain were carefully removed,
weighed and processed for histo-pathological study. Lungs
were removed and used for assessment of status of pul-
monary edema.
Hematological and biochemical tests
About 0.2 ml of blood samples collected from mice car-
diac were used for quantification of total WBCs, lympho-
cytes, monocytes, RBCs, Haemoglobine (Hb), Hematocrit
(HCT), platelets, mean corpuscular volume (MCV), mean
corpuscular hemoglobin concentration (MCHC) and
mean corpuscular hemoglobin (MCH) using CBC ma-
chine (Automated CBC Analyzer: Sysmex KX-21). From1 ml of the blood sample collected in EDTA coated tube,
serum was separated by centrifugation (Centrifuge 4515R)
at 10,000 rpm for 10 minutes. The supernatant was trans-
ferred into new eppendorf tube and immediately followed
by measurement of liver enzymes, serum glutamic oxalo-
acetate transaminase (sGOT) and serum glutamic pyruric
transaminase (sGPT), albumin (Alb), biomarkers of kidney
functions such as creatinine (Cr) and urea, inflammation
biomarkers; uric acid (UA) and C-reactive protein (CRP)
using automated immunochemical analyzer (Axsym
MEIA 3rd Generation).
Pulmonary edema
The status of pulmonary edema was assessed in lungs of
mice infected with PbA and the positive control. The
wet weight of lung was measured immediately after re-
moval of the organ, and the dry weight was determined
after overnight incubation at 80°C. Then, the ratio of
wet to dry weight was calculated to determine the condi-
tion of pulmonary edema [23].
Histopathological analysis
For histological analysis, liver, kidney and brain of sacri-
ficed mice were collected in 10% buffered neutral for-
maldehyde; paraffin-embedded brain, liver and kidney
tissues were sectioned and stained with hematoxylin
and eosin. Slides were coded and scored blind for histo-
logical evidence of cerebral syndromes and liver and
kidney damages.
Anti-plasmodial activity of khat extract
Mice infection and follow up
For this assay, mice grouping and treatment procedures
different from the earlier protocol were used, in that
mice infection was commenced after four weeks of oral
khat treatment. Accordingly, chloroquine sensitive fe-
male Swiss albino mice were grouped into five categories
(n = 40), each containing eight mice. Here, all mice were
initially infected with 1x105 PRBC in PBS intraperiton-
ally. Then, plant extract was solublized in 20% Tween 80
in physiological saline solution and tested in three doses;
100, 500 and 1000 mg/kg administered to the infected
mice (each group contained 8 mice) orally and once
daily for four consecutive days. Other two groups: a
negative control (n = 8) and a positive control (n = 8) re-
ceived 20% Tween 80 in saline solution and 10 mg/kg
base body weight of chloroquine sulphate, respectively.
Suppressive test
Chemo-suppressive activity of the plant crude extract on
parasitemia was evaluated following four day suppressive
test protocol. Blood sample was taken from tail vein of
each mouse on the fourth day p.i. Methanol fixed and
10% Giemsa stained (pH = 7.2 for 10 min) thin film was
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average percentage suppression of parasitemia by the ex-
tract were determined following the formula described
below [24]:
Mean % parasitemia ¼ Total number of pRBCs
Total number of RBCs
 100
Percent parasitemia suppression was calculated by
using the following formula [25].
% parasitemia suppression ¼ Mean parasitemia of control – Mean parasitemia of test
Mean parasitemia of control
 100
Mean survival time of each mouse in all groups was de-
termined by calculating the average survival days of mice in
each group over 30 days. Furthermore, body weight reduc-
tion and temperature rise were monitored every 48 hours
p.i. using digital balance and thermometer, respectively.
Data analysis
Data were checked for their completeness, correctness,
and then double entered into Microsoft Office Excel
(2007) sheet and analyzed using SPSS version 20.0 soft-
ware. The analyzed data were expressed in mean ±
standard error of mean (SEM), otherwise indicated.
One-way analysis of variance (ANOVA) followed by
Tukey’s HSD post-hoc test was employed to compare the
effect of crude khat extract on different variables.
Mantel-Cox Log-rank test was also used to analyze the
survival time between groups. Values of p < 0.05 were
considered statistically significant. All assay results were
mean of triplicate analysis.
Ethical consideration
The study was ethically approved by the Ethical Review
Committee of the College of Health Sciences of Jimma
University, Ethiopia. Detail experimentation procedures
involving mice were managed following the Ethiopian




The acute toxicity study made using the current doses of
khat extracts did not cause any mortality in all mice
within the first 24 h and beyond for period of 14 days.
Physical and behavioural observations of the experimen-
tal mice also revealed no visible signs of overt toxicity
like lacrimation, loss of appetite, tremors, hair erection,
salivation and diarrhea.
Hematological and biochemical features
According to the result of the in vivo study, mice ex-
posed to khat extract followed by PbA infection had sig-
nificantly higher risk of jaundice or liver and renal
impairments. This was evidenced by increased level ofliver enzymes such as serum GPT and GOT, which were
significantly higher (P < 0.001) in blood of mice exposed
to the highest dose of khat extract (300 mg/kg) followed
by PbA infection than the positive control, while albu-
min level was significantly reduced (P < 0.001). However,
creatinine and urea levels did not show any difference
between mice treated with khat followed by PbA infec-
tion and the positive control.
Influence of khat on the status of liver biomarkers was
further observed in mice treated with khat but without
PbA infection, in a dose dependent manner. Serum
GOT and GPT were significantly higher (P < 0.05) in
mice treated with higher dose of khat (300 mg/kg) al-
though albumin level did not show significant differ-
ences (P > 0.05) between mice treated with khat extract
and the negative control. Likewise, in mice treated with
higher dose of khat extract (200 and 300 mg/kg) without
PbA infection, significantly higher (P < 0.05) level of urea
was observed than the negative control, while creatinine
level was only affected at the highest dose (300 mg/kg) of
the khat extract, though it was not detected after PbA in-
fection (Figure 1). However, necrosis of kidney and liver
tissue were observed in the positive control mice treated
with khat followed by PbA infection under all doses.
Inflammation biomarkers such as CRP and UA levels
measured in mice treated with khat extract (100, 200 and
300 mg/kg) did not show significant differences (P > 0.05)
from the negative control. However, in mice treated with
khat extract, under all doses, followed by PbA infection,
significant increment (P < 0.05) in level of UA than the
positive control was observed, while significant rise (P <
0.05) of CRP level was only observed in mice which re-
ceived 300 mg/kg doses of crude khat extract (Figure 2).
WBCs and Hb levels significantly reduced (P < 0.05) in
mice exposed to the highest doses of crude khat extract
(300 mg/kg) followed by PbA infection compared to the
positive controls. In addition, platelets count significantly
reduced (P < 0.05) in mice treated with khat extract of the
two upper doses of this study (200 and 300 mg/kg), while
lymphocyte and RBCs counts were not significantly differ-
ent (P > 0.05) between the two groups. Effect of khat ex-
tract on hematological parameters without PbA infection
also demonstrated the same pattern as in mice treated
with khat extract followed by PbA infection. In mice
treated with the highest dose of crude khat extract
(300 mg/kg), the levels of WBC, Hb, MCV and platelets
counts were significantly affected (P < 0.05) (Table 1).
Mice treated with higher dose (300 mg/kg) of crude
khat extract showed significant increment (P < 0.05) of
monocytes to lymphocyte count ratio (MLCR) compared
to the positive control. But, neutrophils to lymphocyte
count ratio (NLCR) of the two groups (khat treated and
positive control) did not show significant differences
(Figure 3).
Figure 1 Levels of liver and kidney biomarkers (mean ± SEM) of
Swiss albino mice (n = 8) treated with khat extracts (100, 200,
and 300 mg/kg) daily for 4 weeks, and khat treatment followed
by PbA infection [(100, 200 and 300) mg/kg plus PbA infection]
and the controls. Values with asterisk are significantly different
(ANOVA, Tukey’s HSD post-hoc test) from values of the controls.
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infection on hematological parameters showed that
there were significant changes on almost all RBC and
WBC indices in PbA infected mice. HCT, mean corpus-
cular volume (MCV), platelet and lymphocyte level
were significantly reduced (P < 0.001), while WBC,
mean corpuscular hemoglobin (MCH) and meanFigure 2 Level of C-reactive protein (CRP) (a) and uric acid (UA) (b) in
and 300 mg/kg) daily for 4 weeks, and khat treatment followed by Pb
the controls. Values with asterisk are significantly different (ANOVA, Tukey’corpuscular hemoglobin concentration (MCHC) were
significantly increased (P < 0.05) in PbA infected mice
compared to uninfected or negative control (Figure 4).Effect of khat on outcome of PbA infection
Mice exposed to different doses of khat extract (100, 200
and 300 mg/kg) did not show significant difference (P >
0.05) in mean body weight from the control mice during
the four weeks of treatment period. Body weight of the
animals showed an increment starting from the first to
the fourth week of the follow-up period (Figure 5a). Rectal
temperature was <36°C for all groups of mice on the
day of PbA infection (Day 0). Although gradual rising
was observed in all groups, in mice treated with
300 mg/kg of khat extract, significant increment (P <
0.01) of rectal temperature was recorded from day 3 to
7p.i. (Figure 5b). Similarly, there was a gradual decline
in Hb level in mice treated with khat extract followed
by PbA infection. However, a significantly higher re-
duction (P < 0.05) than the positive control mice was
observed after day 5 of p.i. (Figure 5c). Parasite load in
mice exposed to different doses of crude khat extract
(200 and 300 mg/kg) was significantly lower (P < 0.05)
than the control group on the third and fifth day
(Figure 5d), but significant increment (P < 0.001) was
observed on the seventh day of p.i.
Based on the incidence of pulmonary edema assess-
ment, khat extract did not show significant association
with increased susceptibility to respiratory problems
during Plasmodium berghei ANKA infection. This is,
there was no significant difference (P > 0.05) between
pulmonary edema status in khat exposed mice prior to
infection and the positive control (Figure 6).Swiss albino mice (n = 8) treated with khat extracts (100, 200,
A infection [(100, 200 and 300) mg/kg plus PbA infection] and
s HSD post-hoc test) from values of the controls.
Table 1 Hematological analysis of mice treated with khat followed by PbA infection with reference to controls (n = 8)
Group WBC*103/μL RBC *106/ μL Hb (g/dL) HCT (%) MCV (FL) MCH (pg) MCHC g/dL Plt*103/ μL Lym (%)
control (−ve) 3.8 ± 0.18 8.07 ± 0.3 12.72 ± 0.47 44.32 ± 1.67 54.85 ± 0.03 15.76 ± 0.05 28.72 ± 0.13 884.25 ± 32.5 87.2 ± 1.86
100 mg/kg§ 3.52 ± 0.25 8.32 ± 0.29 12.75 ± 0.45 43.42 ± 2.06 52.06 ± 0.64 15.32 ± 0.02 29.46 ± 0.37 810 ± 45.7 80.32 ± 4.23
200 mg/kg§ 2.85 ± 0.09** 8.7 ± 0.1 12.6 ± 0.18 45.1 ± 0.79 52.9 ± 0.55 15.67 ± 0.3 29.52 ± 0.53 766.7 ± 28.5 85.2 ± 1.72
300 mg/kg§ 2.03 ± 0.49** 8.33 ± 0.15 11.66 ± 0.1* 43.02 ± 0.7 51.66 ± 0.58* 15.23 ± 0.2 29.42 ± 0.24 770 ± 17.15* 80.06 ± 2.17
Control (+ve) 6.64 ± 0.93 7.9 ± 1.02 14.14 ± 1.74 39.43 ± 5.55 47.8 ± 1.73 17.96 ± 0.9 37.34 ± 1.3 354 ± 68.73 74.92 ± 4.87
100 mg/kg + PbA§§ 5.14 ± 1.71 6.9 ± 0.72 12.05 ± 1.23 34.47 ± 4.45 48.1 ± 0.89 17.5 ± 1.02 36.2 ± 0.71 328 ± 52 76.12 ± 11.15
200 mg/kg + PbA§§ 4.57 ± 0.94 7.3 ± 0.34 13.18 ± 0.65 37.06 ± 1.62 50.5 ± 1.23 17.3 ± 1.1 34.5 ± 0.64 173 ± 37.02** 81.85 ± 7.67
300 mg/kg + PbA§§ 4.09 ± 1.87* 7.1 ± 0.81 11.86 ± 1.48* 37.13 ± 4.43 50.1 ± 0.91 18.06 ± 0.93 36.1 ± 1.02 107 ± 21.66** 77.17 ± 8.09
NB: Plt = platelet, Lym = lymphocyte, *showed significant difference (P < 0.05), **(P < 0.01). Significance level of uninfected but khat treated mice §were compared with –ve control group, while khat treated mice














Figure 3 Box-plots showing distribution of neutorphil-lymphocyte count ratio (NLCR) (a) and monocyte-lymphocyte count ratio (MLCR)
(b) of Swiss albino mice treated with crude khat extract (100, 200, and 300 mg/kg) followed by PbA infection. There was significant
difference in the MLCR distribution between the positive control and mice treated with 300 mg/kg dose of khat (One way ANOVA, Tukey’s HSD
post-hoc test, P = 0.024).
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On the 7th day of p.i. (last day of survival), cerebral mal-
aria symptoms such as limb paralysis, convulsions, shiv-
ering, neurological syndromes including ataxia, paralysis,
deviation of the head, convulsions, and necrosis of brain
tissue observed in all mice irrespective of treatment
dose. Due to intense brain necrosis, detection of adher-
ence of parasitized RBC to the endothelial cells was
difficult.Figure 4 Hematological parameters (mean ± SEM) of PbA
infected and PbA uninfected Swiss albino mice. Values with
asterisk indicate significant difference from values of the uninfected
mice (ANOVA, Tukey’s HSD post-hoc test).Anti-plasmodial activity of khat
Crude khat extract displayed lower chemo-suppressive ac-
tivity against PbA malaria. Percentage inhibition or sup-
pression analysis showed that under almost all doses of the
khat extract (100-1000 mg/kg), the observed percentage
parasitemia reduction due to the extract was not signifi-
cantly different (P > 0.05) from the positive control mice.
The percentage suppression observed for all dose of the
extract did not exceed 10%. Moreover, maximum survival
time of mice infected with PbA and treated with khat ex-
tract observed was at1000mg/kg, which was only 14 days.
This survival time was significantly lower (P < 0.05) than
the chloroquine sulphate treated mice (had >30 days sur-
vival time). However, the log rank (Mantel-Cox) analysis
showed that the overall survival time of mice treated with
khat extract was significantly longer (P < 0.001) than the
positive control or vehicle mice (Table 2).
Rectal temperature measurement made during the
in vivo anti-plasmodial activity study indicated that mice
treated with higher dose of khat extract (500 and
1000 mg/kg) had significantly reduced (P < 0.05) rectal
temperature than the control. Also, on the 4th day, the
level of hemoglobin and body weight of khat treated mice
were comparably reduced in the same manner the positive
control mice (Table 3). This indicates that during PbA in-
fection in mice, the crude khat extract did not show pre-
ventive property against weight loss and anemic condition.
Discussion
Most of the findings of this in vivo study were in agree-
ment with our earlier epidemiological study conducted on
P. falciparum infected khat chewers. Accordingly, a sig-
nificant change in liver biomarkers in mice treated with
khat extract followed by PbA infection than the control
mice was observed. Change in liver function tests is a
Figure 5 Body weights of Swiss albino mice treated with khat extract daily for four weeks (a), mean rectal temperature (°C) recorded
(b), mean Hb level (g/dL) measured (c), and percentage of parasitemia observed (d) on different days of p.i. of PbA infection.
Figure 6 The status of pulmonary edema (mean ± SEM) of
Swiss albino mice (n = 8) treated with crude khat extract
followed by PbA infection and positive control.
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infection [26]. Malaria associated liver dysfunction is
usually characterized by a rise in serum bilirubin along
with the rise in serum GOT and GPT levels from mild
abnormality to more than three times the upper limit of
normal [27]. Besides, liver and kidney tissues necrosis
observed in a histopathological study further illustrate
the possible involvement of these two organs in metab-
olism and elimination of khat, respectively. Thus, khat
use could increase the risks of liver and renal impair-
ment, severe malaria pathologies.
Anemia is a hallmark of malaria infection that occurs as
a result of intense hemolysis (destruction) of infected
RBCs due to higher parasitemia caused mainly by P. fal-
ciparum [28]. The remarkable reduction of Hb and HCT
level after day 5 of p.i. in mice treated with khat followed
by PbA infection in this study could be an implication for
the relative risk of khat user malaria patients to severe
Table 2 Parasitemia status, survival time and percentage
suppression of parasitemia in infected Swiss albino mice
treated with khat extract in the 4 day suppressive test





Control 21.36 ± 1.32 0.00 8.3 ± 0.11
100 mg/kg 20.7 ± 0.87 3.09 10.8 ± 0.23*
500 mg/kg 19.7 ± 0.65 7.77 11.16 ± 0.68*
1000 mg/kg 19.3 ± 0.22 9.64 13.7 ± 0.52*
CQ (25 mg/kg) 0.00 100 30 ± 0.00
*showed significant difference at P < 0.001, (Kaplan Meier survival analysis,
Mantel-Cox Log-rank test) from values of the control.
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with higher dose of khat was mainly due to hemolysis of
infected RBCs as parasite load on 7dpi which was signifi-
cantly higher. This implies that khat was one of the aggra-
vating factors for incidence of malaria associated anemia
among khat users who lack protective activity against
hyperparasitemia pathology.
Pulmonary edema, one of the most severe forms of
pathophysiology of malaria that involve lung and charac-
terized by increased alveolar capillary permeability leading
to intravascular fluid loss into the lungs [29], was not af-
fected by exposure to khat. Usually, this pathology is asso-
ciated with non-immune individuals with P. falciparum
infections as part of a severe systemic illness [30]. On the
other hand, lower platelet count, a condition known as
thrombocytopenia, was manifested in mice chronically ex-
posed to khat prior to the infection irrespective of dose of
khat extract. This has a remarkable implication for its pos-
sible frequent manifestation among khat user malaria pa-
tients. Such reduction in platelet count usually results
from apoptosis or activation of platelet [31,32] and their
phagocytosis following platelet adherence in the spleen
during malaria infection [33,34].
Although WBC counts do not directly involve in mal-
aria infection, it is generally low to normal due to
localization of the WBCs from the peripheral circulation
to the spleen and other internal organs [35]. Thus, sig-
nificant reduction in total WBC count observed in miceTable 3 Hemoglobin level, rectal temperature, body weight a
with crude khat extract
Group T0 (°C) T4(°C) % change Hb0 (g/dL)
Control 36.2 ± 0.09 38.16 ± 0.14 −1.96 17.6 ± 0.78
100 mg/kg 36.7 ± 0.12 38.2 ± 0.26 −1.5 18.2 ± 0.04
500 mg/kg 36.9 ± 0.32 37.5 ± 0.04 −0.6 17.9 ± 0.01
1000 mg/kg 36.5 ± 0.15 37.3 ± 0.22 −0.8 18.5 ± 0.36
CQ (25 mg/kg) 36.7 ± 0.07 36.5 ± 0.13 0.2 18.3 ± 0.44
NB: T0 = rectal temperature on Day 0, T4 = rectal temperature on Day 4, Hb0 = hem
on Day 0, W4 = body weight on Day 4.treated with highest dose of khat (300 mg/kg) followed
by PbA infection could be attributed to the cytotoxic
property of the khat extract [36].
The PbA infection in Swiss albino mice was reported
to cause neurological problem (the so-called experimen-
tal cerebral malaria) [37] and to cause nearly 100% le-
thality [38]. There is accumulating evidence that the
pathogenesis of cerebral malaria is due to an immune-
pathological reaction giving rise to excessive production
of cytokines such as tumor necrosis factor-alpha (TNF-
α) and interferon gamma (IFN-γ) [39]. As all mice
treated with khat (100 to 300 mg/kg) prior to PbA infec-
tion developed neurological symptoms in the same way as
the positive control, khat had neither blood brain barrier
(BBB) enhancement nor protection potential against cere-
bral malaria. The elevated level of inflammation bio-
markers such as CRP and UA, which triggers secretion of
pro-inflammatory cytokines [40], mediators for incidence
of cerebral malaria pathology, observed in mice treated
with khat extract followed by PbA infection strengthen the
relative risk of khat users to severe malaria pathologies.
Substantial evidences indicated that long term or chronic
use of khat increases the level of uric acid [41-45]. Fur-
thermore, the necrosis of brain tissue observed during
histopathological study, and clinical manifestations such
as ataxia, paralysis, deviation of the head and convulsions
in khat treated mice prior to PbA infection could
strengthen the fact that khat lacks protection against se-
vere malaria pathologies.
In our epidemiological study, the observed reduction
in parasite burden among khat chewer malaria patients
seems that khat has anti-plasmodial activity. However,
following khat treatment extension, the drastic incre-
ment of parasite load in mice treated with higher dose of
khat extract (200 and 300 mg/kg) followed by PbA infec-
tion observed certainly question anti-plasmodial activity of
the khat. Moreover, the result from anti-plasmodial activ-
ity evaluation revealed that except slight reduction on
parasite load in khat treated mice, significant parasite sup-
pression was not observed. In support of this, rise of rectal
temperature, physical deterioration and severe clinical
symptoms appeared in respect to increased parasite loadnd parasite load of infected Swiss albino mice treated
Hb4 (g/dL) % change W0 (g) W4 (g) % change
15.3 ± 0.13 2.3 24.8 ± 0.26 22.6 ± 0.33 2.2
16.3 ± 0.37 1.9 25.4 ± 0.73 23.1 ± 0.41 2.3
15.1 ± 0.53 2.8 26 ± 1.06 23.8 ± 0.158 2.2
15.2 ± 0.25 3.3 25 ± 0.49 23.2 ± 0.14 1.8
18.1 ± 0.09 0.2 27 ± 0.37 26.4 ± 0.28 0.6
oglobin level on Day 0, Hb4 = hemoglobin level on Day 4, W0 = body weight
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treated mice prior to PbA infection. According to Ingyang
et al. [46], in Swiss albino mice infected with PbA, parasit-
emia started progress on the 2nd day of p.i and reached
significant levels from day 4th - 6th and all untreated ani-
mals died by the 6th day of infection. Thus, lack of signifi-
cant effect of khat on some clinical and parasitological
state of khat treated mice on early stage of infection can-
not be due to absolute suppressive effect of khat, but due
to anti-inflammatory activity of the khat [47,48] that can
suppress the effect of inflammatory reactions or due to
cytotoxicity effect of the plant on the parasite [31]. How-
ever, as the parasite load increased and kidney function af-
fected by the parasite and the khat, the inflammation
reaction mediated by the uric acid and some parasite’s
components [glycosylphosphatidylinositol (GPI)] and
toxin released from infected RBC (hemozine) during mal-
aria infection [39] incidence of some pathologies such as
cerebral malaria and other could be exacerbated.
Researchers of epidemiological studies reported the ef-
fect of malaria infection on hematological parameters
differently. Some stated that hematological changes are
unreliable laboratory indicators of malaria in acute un-
complicated P. falciparum malaria [49], while others re-
ported that lower level of some hematological
parameters such as platelet, WBCs, and lymphocyte
counts WBCs, eosinophils, RBCs and Hb level when
used in combination with other clinical and parasito-
logical method could be the most important predictors
of malaria infection [50-53]. Moreover, higher mono-
cytes to lymphocytes count ratio (MLCR) measured in
peripheral blood have directly correlates with risk of
clinical malaria [54]. This might be due to the major role
of the monocytes in the initial stage of innate immune
response by releasing cytokines to respond to malaria in-
fection [55]. In agreement to the second notion, our
in vivo analysis made on association between PbA in-
fected mice and haematological parameters showed that
almost all, except RBCs count and Hb level, haemato-
logical parameters such as WBC, platelet, HCT, MCV,
MCH, MCHC and lymphocyte were more significantly
reduced in PbA infected than in uninfected mice. This
finding supports the possible predictor relevance of mal-
aria risks using haematological indicators. Moreover, the
high MLCR observed in mice treated with highest dose
of crude khat extract (300 mg/kgBW) could be an evi-
dence for increased risk of severe malaria than the posi-
tive control [54].
Conclusions
The finding of this study strengthen an assumption that
khat could exacerbate manifestation of most severe mal-
aria symptoms in mice and lacks chemo-suppressive
property on Plasmodium berghei ANKA parasite.Abbreviations
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